Ivuxolimab |
Catalog No.GC69303 |
Ivuxolimab est un anticorps monoclonal agoniste d'OX40 (également appelé CD134 ; TNFRSF4), OX40 étant un récepteur de co-stimulation exprimé sur les lymphocytes T CD4+ et CD8+ activés. Ivuxolimab possède une activité antitumorale et un potentiel d'activation immunitaire.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2128729-41-7
Sample solution is provided at 25 µL, 10mM.
Review for Ivuxolimab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Ivuxolimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *